These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30732971)

  • 1. Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients?
    Vane MLG; van Nijnatten TJA; Nelemans PJ; Lobbes MBI; van Roozendaal LM; Kooreman LFS; Keymeulen KBMI; Smidt ML; Schipper RJ
    Eur J Surg Oncol; 2019 Apr; 45(4):573-577. PubMed ID: 30732971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
    Helfgott R; Mittlböck M; Miesbauer M; Moinfar F; Haim S; Mascherbauer M; Schlagnitweit P; Heck D; Knauer M; Fitzal F
    Eur J Surg Oncol; 2019 Apr; 45(4):538-543. PubMed ID: 30366878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging.
    Upadhyaya VS; Lim GH; Chan EYK; Fook-Chong SMC; Leong LCH
    Breast J; 2020 Feb; 26(2):162-167. PubMed ID: 31562691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
    Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
    Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement.
    Ugras S; Stempel M; Patil S; Morrow M
    Ann Surg Oncol; 2014 Nov; 21(12):3780-6. PubMed ID: 24952028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
    Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
    Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer.
    Rukanskienė D; Veikutis V; Jonaitienė E; Basevičiūtė M; Kunigiškis D; Paukštaitienė R; Čepulienė D; Poškienė L; Boguševičius A
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183080
    [No Abstract]   [Full Text] [Related]  

  • 9. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
    van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
    Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
    Mamtani A; Barrio AV; King TA; Van Zee KJ; Plitas G; Pilewskie M; El-Tamer M; Gemignani ML; Heerdt AS; Sclafani LM; Sacchini V; Cody HS; Patil S; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3467-3474. PubMed ID: 27160528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between molecular subtypes and lymph node status in invasive breast cancer.
    Si C; Jin Y; Wang H; Zou Q
    Int J Clin Exp Pathol; 2014; 7(10):6800-6. PubMed ID: 25400761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do?
    Leenders MW; Broeders M; Croese C; Richir MC; Go HL; Langenhorst BL; Meijer S; Schreurs WH
    Breast; 2012 Aug; 21(4):578-83. PubMed ID: 22717665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Node-Positive Disease in Estrogen Receptor-Positive Breast Cancer Patients.
    Gallagher J; Elleson KM; Englander K; Chintapally N; Sun W; Whiting J; Laronga C; Lee MC
    J Surg Res; 2024 Mar; 295():327-331. PubMed ID: 38061237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer recurrence according to molecular subtype.
    Shim HJ; Kim SH; Kang BJ; Choi BG; Kim HS; Cha ES; Song BJ
    Asian Pac J Cancer Prev; 2014; 15(14):5539-44. PubMed ID: 25081661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications.
    Cools-Lartigue J; Sinclair A; Trabulsi N; Meguerditchian A; Mesurolle B; Fuhrer R; Meterissian S
    Ann Surg Oncol; 2013 Mar; 20(3):819-27. PubMed ID: 22972506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].
    Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.